Multicenter trial of dynamic cardiomyoplasty for chronic heart failure

Journal of the American College of Cardiology

Volumn 28, Issue 5, 1996, Pages 1175-1180

  Furnary, Anthony P ^a   Jessup, Mariell ^b,d   Moreira, Luiz F P ^c  

^a PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPLASTY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; HEART FAILURE; HEART PERFORMANCE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE;

CARDIAC OUTPUT, LOW; CARDIOMYOPLASTY; CHRONIC DISEASE; FEMALE; HEART; HEART RATE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0030297756     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00298-7     Document Type: Article

References (57)

1. 1. Jesus FR. Breves consideraciones sobre un caso de herida penetrante del corazon. Bol Asoc Med P R 1931;23:380-2.
2. 2. Leriche R. Essai experimentale de traitement de certains infarctus du muyocarde et de l'aneurisme du coeur par une graffe de muscle strie. Bull Soc Nat Chir 1933;59:229-32.
3. 3. Beck CS, Tichy VL. The production of a collateral circulation to the heart. Am Heart J 1935;10:849-73.
4. 4. Kantrowitz A, McKinnon WMP. The experimental use of the diaphragm as an auxiliary myocardium. Surg Forum 1959;9:266-8.
5. 5. Termet H, Chalencon JL, Estour E et al. Transplantation sur le myocarde d'un muscle strie excite par pace-maker. Ann Chir Thorac Cardio Vasc 1966;5:260-3.
6. 6. Hume WJ. Construction of a functioning accessory myocardium. Trans South Surg Assoc 1968;74:200-2.
7. 7. Buller AJ, Eccles JC, Eccles RM. Interaction between motor-neurons and muscles in respect of the characteristic speeds of their responses. J Physiol 1960;150:417-39.
8. 8. Salmons S, Streter FA. Significance of impulse activity in the transformation of skeletal muscle type. Nature 1976;263:30-4.
9. 9. Macoviak JA, Stephenson LW, Armenti F, et al. Electrical conditioning of in situ skeletal muscle for replacement of myocardium. J Surg Res 1982;32: 429-39.
10. 10. Dewar ML, Chiu RC. Cardiomyoplasty and the pulse train stimulator. In: Chiu RCJ, editor. Biomechanical Cardiac Assist: Cardiomyoplasty and Muscle-Powered Devices. Armonk (NY): Futura, 1986:43-58.
11. 11. Carpentier A, Chachques JC. Myocardial substitution with a stimulated skeletal muscle: first successful case [letter]. Lancet 1985;8440:1267.
12. 12. Grandjean PA, Austin L, Chan S, Terpstra, B. Dynamic Cardiomyoplasty: clinical follow-up results. J Cardiac Surg 1991;6 Suppl:80-8.
13. 13. Chachques JC, Grandjean PA, Carpentier A. Patient management and clinical follow-up after cardiomyoplasty. J Cardiac Surg 1991;6 Suppl:89-99.
14. 14. Magovern JA, Furnary AP, Christlieb IY, Kao RL, Park SB, Magovern G. Indications and risk analysis for clinical Cardiomyoplasty. Semin Thorac Cardiovasc Surg 1991;3:145-8.
15. 15. Moreira LFP, Sefrian PJR, Bocchi E, et al. Survival improvement with dynamic cardiomyoplasty in patients with dilated cardiomyopathy. Circulation 1991;84 Suppl III:III-292-302.
16. 16. Delahaye F, Jegaden O, Montagna P, et al. Latissimus dorsi cardiomyoplasty in severe congestive heart failure: the Lyon experience. J Cardiac Surg 1991;6 Suppl:106-12.
17. 17. Furnary AP, Christlieb IY, Magovern JA, Magovern GJ. A standardized nomenclature for latissimus dorsi cardiomyoplasty. J Cardiac Surg 1991;6: Suppl:74-9.
18. 18. Chachques JC, Grandjean PA, Carpentier A. Latissimus dorsi dynamic cardiomyoplasty. Ann Thorac Surg 1989;47:600-4.
19. 19. Chachques JC, Grandjean PA, Bourgeois IM, Carpentier A. Atrial or ventricular assistance using the cardiomyoplasty procedure. In: Chiu RCJ, Bourgeois IM. editors. Transformed Muscle for Cardiac Assist and Repair. Armonk (NY): Futura, 1990:161-77.
20. 20. Chiu RCJ, Odim JNK, Blundell PE, Williams HB. Dynamic cardiomyoplasty. In: Kapoor AS, Laks H, editors. Atlas on Heart and Lung Transplantation. New York: McGraw Hill, 1994:26-34.
21. 21. Jette AM, Davies AR, Cleary PD, et al. The functional status questionnaire: reliability and validity when used in primary care. J Gen Intern Med 1986;1:146-9.
22. 22. Moreira LFP, Bocchi EA, Stolf NAG, Pileggi F, Jatene AD. Current Expectations in dynamic cardiomyoplasty. Ann Thorac Surg 1993;55:299-303.
23. 23. Moreira LFP, Stolf NAG, Bocchi EA, et al. Clinical and left ventricular function outcomes up to five years after dynamic cardiomyoplasty. J Thorac Cardiovasc Surg 1995;109:353-63.
24. 24. Carpentier A, Chachques JC, Acar C, et al. Dynamic cardiomyoplasty at seven years. J Thorac Cardiovasc Surg 1993;106:42-54.
25. 25. Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1993:71:3C-11C
26. 26. Packer M. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. J Am Coll Cardiol 1983;2:841-52.
27. 27. Braunwald E, Colucci WS. Evaluating the efficacy of new inotropic agents. J Am Coll Cardiol 1984;3:1570-4.
28. 28. Packer M. Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope. J Am Coll Cardiol 1988;12:1299-317.
29. 29. Archer TP, Leir CV. Placebo treatment in congestive heart failure. Cardiol 1992;81:125-33.
30. 30. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic heart failure. Am J Cardiol 1985;55:22A-31A.
31. 31. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson J. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circ 1991;83:778-86.
32. 32. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1987;59:634-8.
33. 33. Cohn JN, Archibald DG, Phil AM. et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986;314:1547-52.
34. 34. Waagstein F, Bristow MR, Swedberg K, et al. for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
35. 35. Lee KF, Dignan RJ, Parmar JM, et al. Effects of dynamic cardiomyoplasty on left ventricular performance and myocardial mechanics in dilated cardiomyopathy. J Thorac Cardiovasc Surg 1991;102:124-31.
36. 36. Capouya ER, Gerber RS, Drinkwater DC, et al. Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg 1993; 56:867-71.
37. 37. Mott BD, Misawa Y, Helou J, et al. Effects of adynamic cardiomyoplasty on ventricular function in a rapid pacing heart failure model [abstract]. J Mol Cell Cardiol 1995;27 Suppl:A12.
38. 38. Moreira LF, Bocchi EA, Bacal F, Stolf NAG, Belotti G, Jatene AD. Present trends in clinical experience with dynamic cardiomyoplasty. Artif Organs 1995;19:211-6.
39. 39. Kass DA, Baughman KL, Pak PH, et al. Reverse modeling from cardiomyoplasty in human heart failure; external constraint versus active assist. Circulation 1995;91:2314-8.
40. 40. El Oakley RM, Jarvis JC, Barman D, et al. Factors affecting the integrity of latissimus dorsi muscle grafts: implications for cardiac assistance from skeletal muscle. J Heart Lung Transplant 1995;14:359-65.
41. 41. Lucas CM, van der Veen FH, Cheriex EC, et al. Long-term follow-up (12 to 35 weeks) after dynamic cardiomyoplasty. J Am Coll Cardiol 1993;22:758-67.
42. 42. Lorusso R, Zogno M, La Canna G, et al. Dynamic cardiomyoplasty as an effective therapy for dilated cardiomyopathy. J Card Surg 1993;8:177-83.
43. 43. Lucas CMHB, Dubelaar M-L, VanderVeen FH, et al. A new stimulation protocol for cardiac assist using the latissimus dorsi muscle. PACE 1993;16: 2012-20.
44. 44. Grubb NR, Campanella C, Sutherland GR, Sinclair C, Fox KAA. Optimizing muscle synchronization after dynamic cardiomyoplasty. Eur J Cardiothorac Surg 1995;9:45-9.
45. 45. Furnary AP, Trumble DR, VU TQ, Magovern GJ, Kao RL. Perineural leads and burst stimulation optimize contraction of skeletal muscle. ASAIO Trans 1991;37:M164-6.
46. 46. Schreuder JJ, van der Veen FH, van der Velde ET, et al. Beat-to-beat analysis of left ventricular pressure-volume relation and stroke volume by conductance catheter and aortic modelflow in cardiomyoplasty patients. Circulation 1995;91:2010-7.
47. 47. Letsou GV, Zarif A, Smith A, et al. Latency of skeletal muscle contraction after pulse train stimulation: an important factor in correct timing of skeletal muscle cardiac assist devices. J Surg Res 1994;57:672-6.
48. 48. Gealow KK, Solien EE, Bianco RW, Shumway SJ. Importance of adaptive stimulation of the latissimus dorsi muscle in cardiomyoplasty. ASAIO Trans 1994;40:M253-9.
49. 49. El Oakley RM, Jarvis JC, Barman D, et al. Factors affecting the integrity of latissimus dorsi muscle grafts: implications for cardiac assistance from skeletal muscle. J Heart Lung Transplant 1995;14:359-65.
50. 50. Lorusso R, Borghetti V, De Fabritiis M, Scelsi R, Carraro U, Alfieri O. Pre-operative physical training effects on latissimus dorsi muscle in patients undergoing dynamic cardiomyoplasty: a preliminary report. Basic Appl Myol 1993;3:211-8.
51. 51. Mannion J, Blood V, Bailey W, et al. The effect of basic fibroblast growth factor on the blood flow and morphologic features of a latissimus dorsi cardiomyoplasty. J Thorac Cardiovasc Surg 1996;111:19-28.
52. 52. Steimle AE, Stevenson LW, Fonarow GC, Hamilton MA, Moriguchi JD. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 1994;23:553-9.
53. 53. Chachques JC, Acar C, Portoghese M, et al. Dynamic cardiomyoplasty for long-term cardiac assist. Eur J CT Surg 1992;6:642-8.
54. 54. Furnary A, Magovern J, Christlieb I, Orie JE, Simpson KA, Magovern GJ. Clinical cardiomyoplasty: preoperative factors associated with outcome. Ann Thorac Surg 1992;54:1139-43.
55. 55. Jegaden O, Delahaye F, Finet G, et al. Late hemodynamic results after cardiomyoplasty in congestive heart failure. Ann Thorac Surg 1994;57: 1151-7.
56. 56. Furnary A, Chachques JC, Moreira LFM, et al. Long term outcome, survival analysis, and risk stratification of dynamic cardiomyoplasty. J Thorac Cardiovasc Surg. In press.
57. 57. The Phase II Dynamic Cardiomyoplasty Study Group. Factors associated with acute hospital mortality following a latissimus dorsi cardiomyoplasty [abstract]. J Am Coll Cardiol 1994;23:74A.